Swedish Growth Companies With High Insider Ownership To Watch In June 2024

In This Article:

As the broader European markets face heightened uncertainty due to rising inflation and cautious central bank policies, Sweden's market dynamics offer a unique landscape for investors focusing on growth companies with high insider ownership. Such firms often demonstrate a strong alignment between shareholders' interests and management, which can be particularly appealing in turbulent times. In this context, understanding the intrinsic qualities that contribute to the resilience and potential of these companies becomes crucial. High insider ownership can signal confidence in the company’s prospects from those who know it best—its leaders.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

BioArctic (OM:BIOA B)

35.1%

50.5%

Sileon (OM:SILEON)

33.3%

109.3%

InCoax Networks (OM:INCOAX)

18%

104.9%

KebNi (OM:KEBNI B)

37.8%

90.4%

Calliditas Therapeutics (OM:CALTX)

11.6%

53%

edyoutec (NGM:EDYOU)

14.6%

63.1%

Egetis Therapeutics (OM:EGTX)

17.6%

98.2%

Yubico (OM:YUBICO)

37.5%

42.5%

SaveLend Group (OM:YIELD)

24.9%

103.4%

Click here to see the full list of 82 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Medicover

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medicover AB operates in the healthcare and diagnostic services sector, serving regions including Poland and Sweden, with a market capitalization of approximately SEK 29.81 billion.

Operations: The revenue for the company is primarily generated through Healthcare Services at €1.26 billion and Diagnostic Services at €585.20 million.

Insider Ownership: 11.1%

Medicover, a Swedish growth company with significant insider ownership, has demonstrated robust earnings growth of 1492.9% over the past year and is expected to continue this trend with forecasts showing a 38.2% annual increase. Despite challenges in covering interest payments with earnings and large one-off items impacting financial results, Medicover trades at 51% below estimated fair value. Recent corporate guidance anticipates organic revenue exceeding €2.2 billion by year-end 2025, highlighting its potential amidst a competitive market landscape where it outpaces average Swedish market growth rates in both revenue and earnings.

OM:MCOV B Ownership Breakdown as at Jun 2024
OM:MCOV B Ownership Breakdown as at Jun 2024

Pandox

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB is a hotel property company that specializes in owning, operating, and leasing hotel properties, with a market capitalization of approximately SEK 34.86 billion.